# A Study of Single Dose of LP-003 in Adolescent Subjects

> **NCT07148557** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Longbio Pharma** · enrollment: 6 (actual)

## Conditions studied

- Allergic Diseases

## Interventions

- **BIOLOGICAL:** LP-003 Dose 1 (Single)
- **BIOLOGICAL:** LP-003 Dose 2 (Single)

## Key facts

- **NCT ID:** NCT07148557
- **Lead sponsor:** Longbio Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-09-30
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07148557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07148557, "A Study of Single Dose of LP-003 in Adolescent Subjects". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT07148557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*